FDA Approves First Intravenous Formulation of Acetaminophen
Finally US FDA approves the first and only preparation containing acetaminophen that can be used intravenously.
Preparation:Ofirmev;
Manufacturer:Cadence Pharmaceuticals, Inc
Indications:
- mild to moderate pain,
- moderate to severe pain with adjunctive opioid analgesics,
- reduction of fever.
Special Consideration & Guidelines:
Ofirmev is to be administered only as a 15-minute infusion. Max daily dose should not exceed 4g.
Adverse effects:
nausea,
vomiting,
constipation,
pruritus,
agitation,
atelectasis
Caution:
Caution is advised when treating patients with hepatic impairment or active liver disease, alcoholism, chronic malnutrition, severe hypovolemia, or severe renal impairment.